[January 15, 2018]

US Nucleic Acid Testing/NAT Market 2017-2021 Forecasts and Supplier Shares - Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers - Research and Markets

The "US Nucleic Acid Testing/NAT Market Forecasts and Supplier Shares 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering.

Report Highlights:

Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.

An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.

Five-year test volume and reagent sales forecasts for the following categories:

• Infectious Diseases
• Cancer
• Forensic Testing
• Genetic Diseases
• Paternity Testing/HLA Typing

Review of testing methodologies and instrumentation technologies.

Feature comparison of automated and semiautomated analyzers.

Sales and market shares of leading suppliers.

Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.

Profiles o major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.

Key Topics Covered:

I. Introduction

II. Major Product Development Opportunities

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

V. Potential Market Entry Barriers and Risks

VI. Worldwide Market and Technology Review

VII. U.S.A. Molecular Diagnostics Market

VIII. Competitive Assessments

Companies Mentioned

• Abbott
• Affymetrix
• Agilent Technologies (News - Alert)
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Bio-Rad
• Biokit
• bioMerieux
• Biotest
• CellMark Forensics/LabCorp
• CellMark Forensics/LabCorp
• Cepheid
• Decode Genetics
• Diade
• Diadexus
• Eiken
• Elitech Group
• Enzo
• Exact Sciences
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• Illumina
• Kreatech/Leica
• Li-Cor Biosciences
• Monogram Biosciences/LabCorp
• Myriad Genetics
• Ortho-Clinical Diagnostics
• Perkin Elmer/Caliper
• Proteome Sciences
• Qiagen
• Roche
• Scienion
• Sequenom
• Shimadzu
• Siemens (News - Alert)
• Sierra Molecular
• Takara Bio
• Tecan Group
• Thermo Fisher

For more information about this report visit https://www.researchandmarkets.com/research/gq49nk/us_nucleic_acid?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180115005309/en/

[ Back To TMCnet.com's Homepage ]